HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sivaraman Dandapani Selected Research

Phosphotransferases (Kinase)

12/2012A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sivaraman Dandapani Research Topics

Disease

2Neoplasms (Cancer)
12/2012 - 02/2012
1Bipolar Disorder (Manic Depressive Psychosis)
01/2016
1Malaria
12/2012
1Breast Neoplasms (Breast Cancer)
05/2012
1Chagas Disease (American Trypanosomiasis)
12/2011

Drug/Important Bio-Agent (IBA)

1Serine (L-Serine)FDA Link
01/2016
1Glycogen Synthase Kinase 3IBA
01/2016
1LithiumIBA
01/2016
1Messenger RNA (mRNA)IBA
12/2012
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
12/2012
1Phosphotransferases (Kinase)IBA
12/2012
1Investigational DrugsIBA
12/2012
1Small Molecule LibrariesIBA
05/2012
1HydrazonesIBA
05/2012
1Molecular Probes (Molecular Probe)IBA
02/2012
1ML-162IBA
02/2012
1(4- (bis(4- chlorophenyl)methyl)- 1- piperazinyl)(5- methyl- 4- nitro- 1,2- oxazol- 3- yl)methanoneIBA
02/2012

Therapy/Procedure

1Therapeutics
12/2011